
Postmarketing Analysis Confirms Safety Profile of Lifitegrast for Dry Eye
A study examining the long-term safety of lifitegrast ophthalmic solution 5% (Xiidra) identified no new or changing signals during routine safety monitoring of patients with dry eye disease (DED) across worldwide postmarketing findings.1 Presented at the …